L.A.M. Pharma - Was ist der Unterschied? - 500 Beiträge pro Seite

[frank007]

Was ist der Unterschied zwischen Lipososmen und der entsprechenden Technik und der von L.A.M. patentierten Ionic Polymer Matrix? Denn die Technik, die L.A.M. anbietet klingt nicht sehr neu! Ist das nur "neuer Wein in alten Schläuchen"?? Die Lipososmentechnik ist schon seit über 30 Jahren bekannt und wird im Bereich der Kosmetik schon lange eingesetzt.
Wer kann mir Infos geben. Die Studie von Dr. Hochwimmer habe ich schon gelesen.

[morchel]

Leider fehlt mir das nötige Hintergrundwissen um da eine Auskunft zu erteilen.
Sollte das ganze auf Liposomenbasis basieren, kann ich mir nicht vorstellen das das Patentamt es patentieren würde.
Weiters gebe ich auch die verbesserte Wirksamkeit zu bedenken. Diese hebt sich klar vom Marktführer ab.


morchel

[frank007]

Mein Problem ist halt, daß ich ganz gerne verstehe, was eine Firma macht, bzw. warum sie soviel besser ist als andere.
Damit bin ich eigentlich bisher ganz gut gefahren.

[Apetitaeffchen]

@frank

Spießer!!!

[morchel]

Frank!
Ist immer gut wenn man kritisch was hinterfrägt!

Mich haben die Testergebnisse auf der Webseite überzeugt, die auch von Dr. Hochwimmer angesprochen wurden!

morchel

[SoWhat]

Hallo Morchel,

Dr. Hochwimmer macht das für Geld. Da kann man das Thema schon mal anreissen !

@Frank007

Bis Du näher in der Materie drin. Denke, für die meisten sind das böhmische Dörfer. Danke für Antwort und

good luck

sowhat

[joelu]

und schon wieder heute 2 (gleiche) empfehlungen für LAMP.

ich glaube, wir kriegen noch viel spaß mit dem ding:

TheSUBWAY.com Announces Investment Opinion: Time to Go?


WESTON, Fla., Mar 21, 2002 (BUSINESS WIRE) -- Keep an eye on LAM Pharmaceutical
Corp. (OTCBB: LAMP). The company just released big news. LAMP is down from almost
$6.50 and could be a huge gainer in the short term. Other stock market standouts
include NVIDIA Corporation (Nasdaq: NVDA), down 10% on 19 million shares after
launching new Select Builder Program, Red Hat Inc. (Nasdaq: RHAT), down 18% on 9
million shares after reporting Q4 and Year End Results, Applied Micro Circuits
(Nasdaq: AMCC), down 7% on 5 million shares after news of new product and Gold
Fields Limited (Nasdaq: GOLD), up 6% on 2.2 million shares.

"In a unanimous decision among Fed members, the central bank opted to leave
interest rates unchanged, with the fed funds target remaining at 1.75 percent
Tuesday afternoon. The key lending rate dropped below 2 percent in December,
after the Federal Reserve cut interest rates for the 11th time in just over one
year`s time in an unprecedented bid to revive the ailing U.S. economy," stated
Peter Antipatis. Continued in TheSUBWAY.com`s daily commentary at
http://www.TheSUBWAY.com

All material herein was prepared by Capital Research Group, Inc. (CRG) based
upon information believed to be reliable. The information contained herein is
not guaranteed by CRG to be accurate, and should not be considered to be
all-inclusive. The companies that are discussed in this opinion have not
approved the statements made in this opinion. This opinion contains
forward-looking statements that involve risks and uncertainties. This material
is for informational purposes only and should not be construed as an offer or
solicitation of an offer to buy or sell securities. CRG is not a licensed
broker, broker dealer, market maker, investment banker, investment advisor,
analyst or underwriter. Please consult a broker before purchasing or selling any
securities viewed on http://www.thesubway.com or mentioned herein. CRG has been
compensated by third party shareholders or with cash from the company on behalf
of one or more of the companies mentioned in this opinion. (one hundred and
twenty five thousand lamp) CRG intends to sell its shares. CRG has sold
approximately eighty five thousand lamp shares to date. CRG may sell its shares
for less than the target price given in this opinion. CRG`s affiliates,
officers, directors and employees may also have bought or may buy the shares
discussed in this opinion and may profit in the event those shares rise in
value. CRG will not advise as to when it decides to sell and does not and will
not offer any opinion as to when others should sell; each investor must make
that decision based on his or her judgment of the market.




--------------------------------------------------------------------------------
TheSUBWAY.com Announces Investment Opinion: Strong Pharmaceuticals! NOTE TO EDITORS: The Following Is An Investment Opinion Issued By theSUBWAY.com.


WESTON, FL, Mar 21, 2002 (INTERNET WIRE via COMTEX) -- Keep an eye on LAM
Pharmaceutical Corp. (OTCBB: LAMP). The company just released big news. LAMP is
down from almost $6.50 and could be a huge gainer in the short term. Other stock
market standouts include ADC Telecommunications (Nasdaq: ADCT), down 9% on 6
million shares after forming global alliance with PwC Consulting, PMC-Sierra
Inc. (Nasdaq: PMCS), down 6% on 5 million shares after announcing
interoperability of product with EZchip and J.D. Edwards & Company (Nasdaq:
JDEC), up 2% on 2.8 million shares after expanding Value Calculator. rates have
held at 40-year lows through two Federal Reserve policy-setting meetings, the
first in January, and the last just yesterday. Many economists, though, see the
underpinnings for an eventual unwinding in coming months, saying the Federal
Open Market Committee is beginning to ready market participants for move up in
the intermediate term." Stated Peter Antipatis in TheSUBWAY.com`s daily
commentary. Continued at www.TheSUBWAY.com.

All material herein was prepared by Capital Research Group, Inc. (CRG) based
upon information believed to be reliable. The information contained herein is
not guaranteed by CRG to be accurate, and should not be considered to be
all-inclusive. The companies that are discussed in this opinion have not
approved the statements made in this opinion. This opinion contains
forward-looking statements that involve risks and uncertainties. This material
is for informational purposes only and should not be construed as an offer or
solicitation of an offer to buy or sell securities. CRG is not a licensed
broker, broker dealer, market maker, investment banker, investment advisor,
analyst or underwriter. Please consult a broker before purchasing or selling any
securities viewed on www.thesubway.com or mentioned herein. CRG has been
compensated by third party shareholders or with cash from the company on behalf
of one or more of the companies mentioned in this opinion. (one hundred twenty
five thousand lamp) CRG intends to sell its shares. CRG has sold approximately
eighty five thousand lamp shares to date. CRG may sell its shares for less than
the target price given in this opinion. CRG`s affiliates, officers, directors
and employees may also have bought or may buy the shares discussed in this
opinion and may profit in the event those shares rise in value. Market
commentary provided by Peter Antipatis, CRD number 2955420. CRG will not advise
as to when it decides to sell and does not and will not offer any opinion as to
when others should sell; each investor must make that decision based on his or
her judgment of the market.